In: Journal of Neurology, 2021, no. 268, p. 817–824
Background: Data on cancer prevalence and incidence in multiple sclerosis (MS) patients are controversial. This study is aimed at estimating cancer risk in MS patients. Methods: Nested case–control study using data collected between 01/01/1987 and 28/02/2016 from the United Kingdom Clinical Practice Research Datalink. Cancer diagnoses after first MS code (index date) was counted in 10,204 MS...
|
In: Breast Cancer Research and Treatment, 2014, vol. 143, no. 1, p. 159-169
|
In: Cancer Immunology, Immunotherapy, 2009, vol. 58, no. 10, p. 1701-1713
|
In: Journal of Neural Transmission, 2011, vol. 118, no. 12, p. 1717-1725
|
In: Clinical Rheumatology, 2009, vol. 28, no. 4, p. 403-412
|
In: Calcified Tissue International, 2012, vol. 91, no. 4, p. 225-243
|
In: Zeitschrift für Rheumatologie, 2005, vol. 64, no. 4, p. 222-228
|
In: Journal of Antimicrobial Chemotherapy, 2017, vol. 72, no. 9, p. 2478–2482
Objectives: Detection of rarer carbapenemases is challenging, as it requires molecular assays with comprehensive coverage or the use of phenotypic methods for the detection of carbapenemase activity. We describe a new class A carbapenemase, FRI-2, in an Enterobacter cloacae complex isolate following implementation of an in- house multiplex PCR for the detection of ‘rare’ class A...
|
In: Rheumatology, 2011, vol. 50, p. iii93-iii104
|
In: Rheumatology, 2015, vol. 54, p. i137-i138
|